EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C13H18O7 |
| Net Charge | 0 |
| Average Mass | 286.280 |
| Monoisotopic Mass | 286.10525 |
| SMILES | OCc1ccccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |
| InChI | InChI=1S/C13H18O7/c14-5-7-3-1-2-4-8(7)19-13-12(18)11(17)10(16)9(6-15)20-13/h1-4,9-18H,5-6H2/t9-,10-,11+,12-,13-/m1/s1 |
| InChIKey | NGFMICBWJRZIBI-UJPOAAIJSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor A compound or agent that combines with cyclooxygenases (EC 1.14.99.1) and thereby prevents its substrate-enzyme combination with arachidonic acid and the formation of icosanoids, prostaglandins, and thromboxanes. |
| Applications: | prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. non-steroidal anti-inflammatory drug An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. antipyretic A drug that prevents or reduces fever by lowering the body temperature from a raised state. An antipyretic will not affect the normal body temperature if one does not have fever. Antipyretics cause the hypothalamus to override an interleukin-induced increase in temperature. The body will then work to lower the temperature and the result is a reduction in fever. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| salicin (CHEBI:17814) has functional parent salicyl alcohol (CHEBI:16464) |
| salicin (CHEBI:17814) has role antipyretic (CHEBI:35493) |
| salicin (CHEBI:17814) has role EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor (CHEBI:35544) |
| salicin (CHEBI:17814) has role metabolite (CHEBI:25212) |
| salicin (CHEBI:17814) has role non-narcotic analgesic (CHEBI:35481) |
| salicin (CHEBI:17814) has role non-steroidal anti-inflammatory drug (CHEBI:35475) |
| salicin (CHEBI:17814) has role prodrug (CHEBI:50266) |
| salicin (CHEBI:17814) is a aromatic primary alcohol (CHEBI:33857) |
| salicin (CHEBI:17814) is a aryl β-D-glucoside (CHEBI:28749) |
| salicin (CHEBI:17814) is a benzyl alcohols (CHEBI:22743) |
| Incoming Relation(s) |
| 2'-O-acetylsalicin (CHEBI:137481) has functional parent salicin (CHEBI:17814) |
| 3'-O-acetylsalicin (CHEBI:137482) has functional parent salicin (CHEBI:17814) |
| 6'-O-acetylsalicin (CHEBI:137484) has functional parent salicin (CHEBI:17814) |
| helicin (CHEBI:73235) has functional parent salicin (CHEBI:17814) |
| salicin 6-phosphate (CHEBI:9003) has functional parent salicin (CHEBI:17814) |
| tremuloidin (CHEBI:155892) has functional parent salicin (CHEBI:17814) |
| willow bark extract (CHEBI:79395) has part salicin (CHEBI:17814) |
| IUPAC Name |
|---|
| 2-(hydroxymethyl)phenyl β-D-glucopyranoside |
| Synonyms | Source |
|---|---|
| Salicin | KEGG COMPOUND |
| Salicoside | KEGG COMPOUND |
| 2(hydroxymethyl)phenyl-beta-D-glucopyranoside | ChEBI |
| 2-(hydroxymethyl)phenyl-β-D-glucopyranoside | ChEBI |
| 2-(hydroxymethyl)phenyl-O-β-D-glucopyranoside | ChEBI |
| D-(−)-salicin | ChEBI |
| UniProt Name | Source |
|---|---|
| salicin | UniProt |
| Citations |
|---|